First Trust NYSE Arca Biotechnology Index Fund
213 hedge funds and large institutions have $959M invested in First Trust NYSE Arca Biotechnology Index Fund in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 70 increasing their positions, 72 reducing their positions, and 33 closing their positions.
239% more call options, than puts
Call options by funds: $1.3M | Put options by funds: $385K
0.12% less ownership
Funds ownership: 49.07% → 48.95% (-0.12%)
3% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 72
5% less funds holding
Funds holding: 224 → 213 (-11)
8% less capital invested
Capital invested by funds: $1.05B → $959M (-$86.9M)
30% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 33
70% less funds holding in top 10
Funds holding in top 10: 10 → 3 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$8.06M |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$7.66M |
| 3 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
+$4.47M |
| 4 |
IMC Chicago
Chicago,
Illinois
|
+$3.4M |
| 5 |
LPL Financial
San Diego,
California
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$12.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$7.62M |
| 3 |
MML Investors Services
Springfield,
Massachusetts
|
-$6.36M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.23M |
| 5 |
3F
360 Financial
Wayzata,
Minnesota
|
-$5.59M |
FBT Hedge Fund Activity: Q3 2020 in Review
213 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2020, worth a combined $959M — down 8.3% from $1.05B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of FBT and 23 opened new positions — a net loss of 10 holders — while 72 trimmed existing stakes and 70 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $8.06M. The largest seller was Morgan Stanley, cutting an estimated $12.9M.
- 213 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2020, down from 224 in Q2 2020.
- Funds reported $959M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2020, down 8.3% quarter-over-quarter.
- 23 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2020 and 33 closed out, a net change of -10 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2020 was HRT Financial, an estimated $8.06M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2020 was Morgan Stanley, an estimated $12.9M sold.
Based on aggregated 13F filings for Q3 2020.